These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 10858342

  • 21. Caspofungin in combination with amphotericin B against Candida glabrata.
    Barchiesi F, Spreghini E, Fothergill AW, Arzeni D, Greganti G, Giannini D, Rinaldi MG, Scalise G.
    Antimicrob Agents Chemother; 2005 Jun; 49(6):2546-9. PubMed ID: 15917570
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Caspofungin: an echinocandin antifungal agent.
    Stone EA, Fung HB, Kirschenbaum HL.
    Clin Ther; 2002 Mar; 24(3):351-77; discussion 329. PubMed ID: 11952021
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. In vitro susceptibilities of Candida dubliniensis isolates tested against the new triazole and echinocandin antifungal agents.
    Pfaller MA, Messer SA, Gee S, Joly S, Pujol C, Sullivan DJ, Coleman DC, Soll DR.
    J Clin Microbiol; 1999 Mar; 37(3):870-2. PubMed ID: 9986880
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Use of fluorescent probes to determine MICs of amphotericin B and caspofungin against Candida spp. and Aspergillus spp.
    Peter J, Armstrong D, Lyman CA, Walsh TJ.
    J Clin Microbiol; 2005 Aug; 43(8):3788-92. PubMed ID: 16081911
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Amphotericin B-resistant Aspergillus flavus infection successfully treated with caspofungin, a novel antifungal agent.
    Koss T, Bagheri B, Zeana C, Romagnoli MF, Grossman ME.
    J Am Acad Dermatol; 2002 Jun; 46(6):945-7. PubMed ID: 12063497
    [Abstract] [Full Text] [Related]

  • 34. Caspofungin: a review of its use in oesophageal candidiasis, invasive candidiasis and invasive aspergillosis.
    Keating G, Figgitt D.
    Drugs; 2003 Jun; 63(20):2235-63. PubMed ID: 14498760
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC.
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.